Pollak 2008) has linked elevated circulating IGF-1 to higher risk of certain cancers in human cohorts
BPC-157 (Body Protection Compound-157) lyophilized powder, 15-amino-acid sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), 99% purity (HPLC verified)
Other potential side effects of BPC 157 may include allergic reactions, issues at the injection site, and systemic complications
The products are not medicines or drugs and they have not been approved by the fda to prevent, treat, diagnose, mitigate, or cure any disease, ailment or medical condition
Also remember: Monitor for allergic reactions
Its multi-use vial format allows repeated access in controlled environments while maintaining product integrity